INDIGO: A global, randomized, double-blind, phase III ...

Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting Virtual Format, May 29–31, 2020 Email: medinfo@agios.com D a y –28 Every month Every 2 months thereafterb Month Screening 2 12 24 36 Randomization/C1D1 Acknowledgments We thank the participating patients and their families. Disclosures ................
................